Mozambique

  1. The New Nets Project was established with the goal of making the latest resistance breaking net technology more widely available to malaria programs throughout Africa. As well as managing the rapid deployment of new nets to partner countries and negotiating a volume guarantee to reduce prices, the New Nets Project partners oversee randomized control trials and pilots. The evidence gathered from these will be used to ascertain the impact and cost-effectiveness of the nets and support an appropriate policy recommendation from the World Health Organization. The New Nets Project is co-funded by Unitaid and The Global Fund, with complementary funding provided by the Bill & Melinda Gates Foundation and USAID. The project is led by IVCC. This slide deck shares interim findings across the epidemiology, entomology, human behavior, and durability monitoring components of the five observational studies led by PATH.
    Published: August 2022
    Resource Page
    Presentation
  2. The New Nets Project was established with the goal of making the latest resistance breaking net technology more widely available to malaria programs throughout Africa. As well as managing the rapid deployment of new nets to partner countries and negotiating a volume guarantee to reduce prices, the New Nets Project partners oversee randomized control trials and pilots. The evidence gathered from these will be used to ascertain the impact and cost-effectiveness of the nets and support an appropriate policy recommendation from the World Health Organization (WHO). The New Nets Project is co-funded by Unitaid and The Global Fund, with complementary funding provided by the Bill & Melinda Gates Foundation and USAID. The project is led by IVCC. This report shares interim findings from the five observational studies led by PATH.
    Published: July 2022
    Resource Page
    Report
  3. This report focuses on bed net indicators collected from annual cross-sectional surveys and anthropological activities. Within each evaluation, available indicators on bed net ownership, bed net characteristics, and bed net use are presented. Due to country-specific factors, the timing of data collection, management, and analysis varies. Data collection and analysis are ongoing, and definitive conclusions will not be drawn from these results at this time.The New Nets Project (NNP) was established with the goal of making the latest dual active ingredient (AI) insecticide-treated nets (ITNs) more widely available to malaria programs throughout sub-Saharan Africa. In addition to managing the rapid deployment of new nets to partner countries and negotiating a volume guarantee to reduce prices, NNP partners oversee randomized control trials and pilot studies evaluating their efficacy and effectiveness. The evidence gathered from these studies will be used to ascertain the impact and cost-effectiveness of dual AI nets and support an appropriate ITN policy recommendation from the World Health Organization. The NNP is co-funded by Unitaid and The Global Fund, with complementary funding provided by the Bill & Melinda Gates Foundation and US President’s Malaria Initiative. The project is led by IVCC.
    Published: May 2022
    Resource Page
    Report
  4. The goal of the antenatal care (ANC)-based malaria surveillance study is to assess the potential for pregnant women attending their first ANC visit to be used as an easy-to-access sentinel population at health facilities to monitor trends in prevalence of malaria infection and the coverage of malaria control interventions in study districts, correlated with similar metrics obtained during annual community-based cross-sectional surveys (CSS). The New Nets Project (NNP) is conducting annual cross-sectional surveys in three study districts each in Burkina Faso and western Mozambique and in four study local government areas in Nigeria, with the primary aim of evaluating the impact of next-generation dual active ingredient insecticide-treated nets (ITNs) compared to standard pyrethroid-only ITNs. Through funding from the Bill & Melinda Gates Foundation and The Global Fund, testing for malaria of all pregnant women at during their first ANC visit is being implemented at select health facilities in NNP study districts for two years (2020–2022).This descriptive report presents a summary of preliminary results generated from the first months of data collection in Burkina Faso, Mozambique, and Nigeria. It begins with an overview of the study sites and timeline, followed by a summary of the study population and data collection and analysis methods. The findings from each country are then presented, including prevalence and ITN and care-seeking indicators. Each country section closes with a discussion on the ANC-based surveillance results and how they seemingly compare to results from the annual household CSSs from the NNP.
    Published: May 2022
    Resource Page
    Report
  5. Mosquito nets treated with new ingredients show greater reductions in malaria than standard insecticide-treated nets.
    Published: December 2021
    Article
  6. From June 2019 to March 2020, eight health facilities in two districts of Maputo Province participated in a pilot intervention where maternal and child health (MCH) nurses working at postnatal care (PNC) services screened and counseled women for postpartum depression (PPD) and collaborated with mental health providers to follow up on women with symptoms of depression.The assessment, conducted in the second half of 2020, set out to evaluate the following aspects of the pilot:The effectiveness of provider training and supervision.The acceptability and feasibility of screening and counseling for PPD in routine PNC.The barriers and facilitators of integrating postpartum screening and counseling in routine care.The PPD detection rates achieved by the nurses.
    Published: August 2021
    Resource Page
    Brief
  7. Together with over 400 external stakeholders from across 50 countries, PATH has crafted a new institutional strategy that responds to the current crises we face as a global community, to the needs and priorities of our local partners, and to the resounding calls for the continued transformation of our sector. To bring our new strategy to life for our external partners, we’ve developed a strategy brochure. The brochure explains why PATH exists (our mission), what we will do (our priorities) and, perhaps most importantly, how we will do it (our change strategies).
    Published: June 2021
    Resource Page
    Brief
  8. The Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments, and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.This report presents findings synthesized across the eight PCE countries in 2020 presenting a comprehensive look at the Global Fund grant cycle. The PCE assessed how business model factors have facilitated or hindered the achievement of objectives during implementation of grants approved during the 2017-19 funding cycle, including around Resilient and Sustainable Systems for Health (RSSH), sustainability and equity, and whether lessons learned during current grants have informed the next funding cycle. The objective of this grant cycle analysis was to understand what, when, why, and how grant investments change over time, including significant factors that influenced the implementation of and changes to the original grant.
    Published: February 2021
    Resource Page
    Report
  9. The New Nets Project, a partnership funded by Unitaid and the Global Fund and led by IVCC, aims to accelerate the scale-up of next-generation, dual-active ingredient ITNs and to provide National Malaria Control Programs, donors, and implementers with clear evidence of their impact on malaria burden.
    Published: September 2020
    Resource Page
    Brief
  10. This brief summarizes the experience and capabilities of the PATH Cervical Cancer Team. For decades, PATH has been at the forefront of evidence-based strategies from HPV vaccine research and delivery to cervical cancer screening and treatment to ensure we best meet the needs and realities of these countries for the greatest health impact.
    Published: June 2020
    Resource Page
    Brief